Ausnutria Dairy Corporation Ltd (1717) announced a clarification related to its Probiotics Supply Framework Agreement. According to the revised information, the annual cap for the transactions under this agreement has been adjusted to RMB10 million for the financial year ending 31 December 2025, RMB40 million for 2026, and RMB65 million for 2027.
All other details previously disclosed remain unchanged. The clarification follows the company’s announcement on 31 October 2025, reaffirming the scope and parameters of the ongoing connected transaction.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.